iKang Healthcare (KANG) Reports Q2 EPS of $0.09

Go back to iKang Healthcare (KANG) Reports Q2 EPS of $0.09

iKang Announces Unaudited Financial Results for the Second Quarter Ended September 30, 2016

December 1, 2016 5:00 PM EST

BEIJING, Dec. 01, 2016 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), the largest provider in Chinas fast growing private preventive healthcare services market with a market share of 13.6% in terms of revenue in calendar year 2014, today announced its unaudited financial results for the second quarter ended September 30, 2016.

Fiscal Second Quarter Ended September 30, 2016 Financial Highlights

Net revenues were US$119.7 million, an increase of 21.4% year-over-year (an increase of 28.3% on RMB basis) (1) Gross profit was US$54.1 million, an increase of 19.0% year-over-year (an... More